- A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.
Modular is seeking FDA approval for human use validation after conducting trials under US IRB approval.
9 reports, 1 independent
Updated Aug 3
Gone quiet
- Reports
- 9
- Developments
- 1
- Repetition
- 89%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Modular is seeking FDA approval for human use validation after conducting trials under US IRB approval.
Who's involved
What this event is mainly aboutKeep exploring
Part of
A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Also in this story
- A partnership with BARDA has accelerated the development of SCY-247 for the company.
- A company plans to submit regulatory applications to the FDA, EMA, and Australian TGA.
- Approval leads to procurement process initiation.
- UroGen Pharma Ltd., headquartered in Princeton, is seeking FDA approval for its products for the U.S. market.
The entities involved
Related events
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- FDA approval enables commercial availability for a product associated with Indianapolis.
- Unregulated products are bypassing official government approval processes.
- FDA and Pfizer are seeking regulatory approval for their products.
- FDA approval expands patient access to therapies for ACCORD.
Coverage
Newest first; wire copies grouped- ACCESS NewswireModular Medical Announces First Human Use of MODD1 Pump Delivering Insulin - Use of MODD1 on clinician with Type 1 diabetes - Modular Medical intends to deploy the MODD1 on a larger number of clinici